Total submissions: 9
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000285599 | SCV000345878 | uncertain significance | not provided | 2017-12-07 | criteria provided, single submitter | clinical testing | |
Labcorp Genetics |
RCV001079454 | SCV000630827 | likely benign | Walker-Warburg congenital muscular dystrophy | 2025-01-30 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000285599 | SCV001475115 | uncertain significance | not provided | 2020-02-24 | criteria provided, single submitter | clinical testing | |
Ambry Genetics | RCV002348030 | SCV002623291 | likely benign | Cardiovascular phenotype | 2023-04-13 | criteria provided, single submitter | clinical testing | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. |
Revvity Omics, |
RCV000285599 | SCV003832614 | uncertain significance | not provided | 2021-02-17 | criteria provided, single submitter | clinical testing | |
Gene |
RCV000285599 | SCV003923352 | uncertain significance | not provided | 2024-08-05 | criteria provided, single submitter | clinical testing | Previously reported as heterozygous in an individual with suspected limb girdle muscular dystrophy (PMID: 30564623); In silico analysis supports that this missense variant has a deleterious effect on protein structure/function; Missense variants in this gene are a common cause of disease and they are underrepresented in the general population; This variant is associated with the following publications: (PMID: 32906206, 27439679, 30564623) |
Mayo Clinic Laboratories, |
RCV000285599 | SCV005408874 | uncertain significance | not provided | 2024-02-29 | criteria provided, single submitter | clinical testing | PP3 |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV005238861 | SCV005885760 | likely benign | not specified | 2025-02-10 | criteria provided, single submitter | clinical testing | Variant summary: FKRP c.1154C>T (p.Ser385Leu) results in a non-conservative amino acid change in the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 0.00013 in 1611398 control chromosomes, predominantly at a frequency of 0.0026 within the African or African-American subpopulation in the gnomAD database. The observed variant frequency within African or African-American control individuals in the gnomAD database is higher than the estimated maximal expected allele frequency for a pathogenic variant in FKRP causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive phenotype (0.0024). c.1154C>T has been reported in the literature in individuals affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (Nallamilli_2018). These report(s) do not provide unequivocal conclusions about association of the variant with Limb-Girdle Muscular Dystrophy, Autosomal Recessive. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publication have been ascertained in the context of this evaluation (PMID: 30564623). ClinVar contains an entry for this variant (Variation ID: 291171). Based on the evidence outlined above, the variant was classified as likely benign. |
Prevention |
RCV004537622 | SCV004745875 | likely benign | FKRP-related disorder | 2022-09-20 | no assertion criteria provided | clinical testing | This variant is classified as likely benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications). |